Save the Date
Bridging Innovation Through PSMA
March 26-27, 2026
San Francisco
Co-Hosted Event
The PSMA & Beyond Conference, co-hosted by the University of California, Los Angeles (UCLA) and the University of California, San Francisco (UCSF), with support from the Prostate Cancer Foundation (PCF), will focus on the current and future use of PET imaging and radionuclide therapy, including presentations, panel discussions, and exhibits from invited speakers and stakeholders.

Welcome

We are thrilled to welcome you—whether in person or virtually—to the 2026 PSMA & Beyond Conference.

This year’s program offers a comprehensive exploration of key topics shaping the future of prostate cancer diagnosis and treatment, including:

  • PSMA PET Imaging: A deep dive into the nuances of interpreting and reporting PSMA PET scans, backed by current evidence and its relevance to patient care.
  • PSMA-Targeted Radioligand Therapy: Explore best practices for patient selection and optimal management strategies for this innovative therapeutic approach.
  • Combination Therapy & Future Trials: A critical examination of combination treatment strategies, the potential of emerging clinical trials, and the vital role of dosimetry.
  • Tumor Boards: Interactive sessions featuring tumor boards to highlight the clinical impact of PSMA imaging and therapy in real-world prostate cancer cases.

We look forward to an inspiring and informative event that drives meaningful progress in the field.

Past Events

The 2025 PSMA & Beyond Conference was a great success! Thank you to all of our sponsors, speakers, and attendees for the incredible support and engagement. Check out the photo gallery for key highlights!